Europe

Apr 02, 2015
By
In Europe drug pricing concerns are continuing to invade the hitherto sacrosanct territory of drug development, writes Peter O'Donnell.
Mar 16, 2015
The EU’s proposed new study on off-label prescribing is just another way of kicking the issue into the long grass, writes Reflector.
Mar 11, 2015
By
March 11, 2015.
Mar 04, 2015
From Applied Clinical Trials
By
President Obama's January announcement of an initiative in precision medicine has set Europe a-flutter over the term 'personalized medicine', writes Peter O'Donnell.
Mar 04, 2015
Will the EU's proposed STAMP halt its progress on MAPPs (medicine adaptive pathways to patients)? Reflector reports.
Mar 02, 2015
Pharmaceutical Executive Europe
The debate around NICE's threshold for cost effectiveness has always been heated; recent theories add more fuel to the fire, writes Leela Barham.
Feb 17, 2015
By
February 17, 2015.
Feb 03, 2015
By
The French pharmaceutical market is forecast to grow at a "tepid" CAGR of 0.7% from $46.2 billion in 2014 to $48.2 billion by 2020, according to GlobalData.
Feb 02, 2015
Pharma and healthcare are among the many areas being viewed with increasing attention inside and outside Greece, following the victory in the country’s elections of the radical left-wing, anti-austerity Syriza party.
Jan 30, 2015
By
Findings from the joint report on the occurrence of antimicrobial resistance in bacteria from humans and food-producing animals.
native1_300x100
подробнее

www.steroid.in.ua
lorem ipsum